Unknown

Dataset Information

0

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice.


ABSTRACT: Among genetically engineered mouse models of breast cancer, MMTV-PyVT is a mouse strain in which the oncogenic polyoma virus middle T antigen is driven by the mouse mammary tumor virus promoter. The aim of the present study was to perform morphologic and genetic analyses of mammary tumors arising from MMTV-PyVT mice. To this end, mammary tumors were obtained at 6, 9, 12, and 16 weeks of age for histology and whole-mount analyses. We conducted whole-exome sequencing to identify constitutional and tumor-specific mutations, and genetic variants were identified using the GRCm38/mm10 mouse reference genome. Using hematoxylin and eosin analysis and whole-mount carmine alum staining, we demonstrated the progressive proliferation and invasion of mammary tumors. Frameshift insertions/deletions (indels) were noted in the Muc4. Mammary tumors showed small indels and nonsynonymous single-nucleotide variants but no somatic structural alterations or copy number variations. In summary, we validated MMTV-PyVT transgenic mice as a multistage model for mammary carcinoma development and progression. Our characterization may be used as a reference for guidance in future research.

SUBMITTER: Liu CL 

PROVIDER: S-EPMC10297447 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice.

Liu Chien-Liang CL   Huang Wen-Chien WC   Cheng Shih-Ping SP   Chen Ming-Jen MJ   Lin Chi-Hsin CH   Chang Shao-Chiang SC   Chang Yuan-Ching YC  

Current issues in molecular biology 20230524 6


Among genetically engineered mouse models of breast cancer, MMTV-PyVT is a mouse strain in which the oncogenic polyoma virus middle T antigen is driven by the mouse mammary tumor virus promoter. The aim of the present study was to perform morphologic and genetic analyses of mammary tumors arising from MMTV-PyVT mice. To this end, mammary tumors were obtained at 6, 9, 12, and 16 weeks of age for histology and whole-mount analyses. We conducted whole-exome sequencing to identify constitutional and  ...[more]

Similar Datasets

| S-EPMC2244686 | biostudies-literature
| S-EPMC1257467 | biostudies-literature
2014-02-01 | GSE54582 | GEO
| S-EPMC4032816 | biostudies-literature
2014-02-01 | E-GEOD-54582 | biostudies-arrayexpress
2025-03-24 | GSE292678 | GEO
| S-EPMC2813429 | biostudies-literature
| S-EPMC6368957 | biostudies-literature
| S-EPMC10001983 | biostudies-literature
| S-EPMC5964334 | biostudies-literature